Top Markets
Coin of the day
Nuformix plc Nuformix plc

Nuformix plc

NFX
Pozycja w akcjach #20651
Nuformix plc operates in the field of pharmaceutical development for treating... Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis. It also has an option agreement with Oxilio Ltd. for NXP001 for oncology indications. Nuformix plc was founded in 2008 and is based in London, the United Kingdom.
Cena akcji
$0.00244926
Kapitalizacja rynkowa
$51.67K
Zmiana (1 dzień)
5.88%
Zmiana (1 rok)
110.15%
Kraj
GB
Handel Nuformix plc (NFX)

Kategoria

Historia ceny akcji dla Nuformix plc (NFX)
Najwyższa cena zamknięcia: $0.00 dnia 2026-03-01

Najniższa cena zamknięcia: $0.04 dnia 2015-12-01
Historia cen akcji firmy Nuformix plc od 2015 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 0.00%
2025 411.32%
2024 -82.51%
2023 -11.70%
2022 -74.73%
2021 -56.41%
2020 -60.57%
2019 249.10%
2018 -26.41%
2017 -13.50%
2016 17.74%
2015 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$36.04 -48.63%
DK
$433.07 -13.83%
US
$737.71 16.02%
US
$298.91 66.79%
BE
$100.99 -36.10%
AU